All companies, by market cap
505 companies and 2079 sets of results: the S&P 500, and sometimes a company from outside it. We can draw the statement for 418.
| # | Company | Market cap | Share price | Revenue | Quarter |
|---|---|---|---|---|---|
| 51 |
|
$196B | $182.90 +0.3% | $92.2B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 TMUS T-Mobile US |
| 52 |
|
$191B | $218.82 −7.3% | $9.5B Last four quarters 2027: Q1, Q2 · 2026: Q3, Q4 | Q2 FY27 MRVL Marvell Technology |
| 53 |
|
$189B | $180.15 −1.0% | $44.1B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 QCOM Qualcomm |
| 54 |
|
$188B | $108.59 +1.9% | $98.9B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 DIS Walt Disney |
| 55 |
|
$186B | $136.34 +0.0% | $96.9B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 PEP PepsiCo |
| 56 |
|
$183B | $805.55 −3.0% | $12.2B Last four quarters 2026: Q1, Q2, Q3, Q4 | Q4 FY26 STX Seagate Technology |
| 57 |
|
$182B | $257.49 +2.0% | $27.7B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 MCD McDonald's |
| 58 |
|
$182B | $26.51 +1.7% | $127.2B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 T AT&T |
| 59 |
|
$182B | $146.41 +1.9% | $29.7B Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 | Q1 FY26 GILD Gilead Sciences |
| 60 |
|
$178B | $103.09 +1.1% | $45.1B Last four quarters 2026: Q1 · 2025: Q2, Q3, Q4 | Q1 FY26 ABT Abbott Laboratories |
| 61 |
|
$176B | $361.02 −4.7% | $13.9B Last four quarters 2026: Q1, Q2, Q3 · 2025: Q4 | Q3 FY26 ADI Analog Devices |
| 62 |
|
$170B | $81.63 −0.8% | $7.4B 1 of four quarters in a row 2025: Q3 | Q3 FY25 NEE NextEra Energy |
| 63 |
|
$169B | $285.08 +0.2% | $25.4B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 UNP Union Pacific |
| 64 |
|
$166B | $210.27 −0.1% | $46.8B 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 BA Boeing |
| 65 |
|
$158B | $27.72 +0.0% | $14.5B 1 of four quarters in a row 2026: Q1 | Q1 FY26 PFE Pfizer |
| 66 |
|
$154B | $426.94 −4.5% | $12.9B Last four quarters 2026: Q1, Q2, Q3, Q4 | Q4 FY26 WDC Western Digital |
| 67 |
|
$153B | $393.16 −7.6% | $16.0B 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 ETN Eaton |
| 68 |
|
$148B | $72.63 +1.3% | $55.2B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 UBER Uber |
| 69 |
|
$147B | $142.35 +7.4% | $14.7B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 NOW ServiceNow |
| 70 |
|
$143B | $203.25 +1.6% | $25.1B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 DHR Danaher |
| 71 |
|
$139B | $125.99 +0.0% | $29.5B 2 of four quarters in a row 2027: Q1, Q2 | Q2 FY27 TJX TJX Companies |
| 72 |
|
$134B | $377.94 +2.4% | $11.0B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 ISRG Intuitive Surgical |
| 73 |
|
$132B | $175.35 +0.8% | $28.2B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 BKNG Booking |
| 74 |
|
$132B | $519.51 +0.8% | $12.6B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 | Q2 FY26 VRTX Vertex Pharmaceuticals |
| 75 |
|
$131B | $64.10 +0.7% | $24.5B 2 of four quarters in a row 2026: Q1, Q2 | Q2 FY26 BMY Bristol Myers Squibb |
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.